市场调查报告书
商品编码
1394986
外泌体市场 - 按产品和服务(试剂盒和试剂、仪器)、应用(诊断、治疗)、适应症(癌症、传染病)、最终用户(製药和生物技术公司)、预测,2023-2032 年Exosomes Market - By Products & Services (Kits & Reagents, Instruments), Application (Diagnostic, Therapeutic), Indication (Cancer, Infectious Diseases), End-users (Pharmaceutical & Biotechnology Companies), Forecast, 2023-2032 |
由于再生医学和细胞疗法的采用不断增加,2023-2032 年外泌体市场规模预计将以 29.9% 的CAGR扩大。
人们对再生医学的日益关注,特别是对干细胞疗法的重视,正在推动对基于外泌体的治疗的需求。由于外泌体具有转运核酸和蛋白质等生物活性分子的能力,因此外泌体已成为治疗介入的有希望的候选者。此外,一些市场参与者正在与当地医学研究机构合作进行创新研究,重点关注外泌体的再生潜力,进一步增强产业前景。举个例子,2023年9月,dG医疗集团启动了利用间质干细胞外泌体治疗重大疾病的研究。
外泌体产业分为产品和服务、应用、适应症、最终用户和地区。
根据产品和服务,预计 2023 年至 2032 年仪器领域的市占率CAGR将达到 25.5%。专为外泌体分离、表征和分析而设计的专用仪器在推进外泌体研究方面有着巨大的需求。高性能超速离心系统、微流体装置和创新的分析平台也使得外泌体的精确处理和研究成为可能。此外,外泌体仪器技术的不断进步正在提高流程的可扩展性和可靠性,以满足研究和临床社区不断变化的需求。
在应用方面,预计到2032 年,诊断领域的外泌体产业规模将实现25.8% 的成长率。外泌体提供非侵入性的检测和监测疾病的方法,例如癌症、神经退化性疾病和传染病。此外,对早期准确疾病检测的需求不断增长,加上外泌体分离和分析技术的进步,将推动该领域的扩张。
从区域来看,由于该地区研究活动不断增加以及生物技术和医疗保健产业不断扩大,预计到 2032 年,亚太地区外泌体市场将呈现强劲成长。慢性病盛行率的上升以及人们对精准医疗的兴趣日益浓厚,使得基于外泌体的诊断和治疗的需求激增。此外,几个亚洲国家的研究机构和生技公司之间不断加强的合作正在促进外泌体应用的创新,并推动区域产业的成长。
Exosomes Market size is poised to expand at 29.9% CAGR from 2023-2032 driven by increasing adoption in regenerative medicine and cell-based therapies.
The growing focus on regenerative medicine, with particular emphasis on stem cell therapies is driving the demand for exosome-based treatments. On account of their ability to transport bioactive molecules, such as nucleic acids and proteins, exosomes have emerged as promising candidates for therapeutic interventions. Furthermore, several market players are collaborating with local medical research institutes to conduct innovative studies to focus on regenerative potential of exosomes, further augmenting the industry outlook. To cite an instance, in September 2023, dG Medical Group launched research on the use of mesenchymal stem cell exosomes to treat major medical disorders.
The exosomes industry is segmented into products & services, application, indication, end-user, and region.
Based on products & services, the market share from the instruments segments is anticipated to record 25.5% CAGR from 2023-2032. Specialized instruments designed for exosome isolation, characterization, and analysis are witnessing significant demand in advancing exosome research. High-performance ultracentrifugation systems, microfluidic devices, and innovative analytical platforms also enable precise handling and study of exosomes. Moreover, the rising technological advancements in exosome instrumentation are leading to improved scalability and reliability of processes for meeting the evolving needs of the research and clinical communities.
In terms of application, the exosomes industry size from the diagnostic segment is estimated to record 25.8% growth rate through 2032. Exosomes offer non-invasive means of detecting and monitoring diseases, such as cancer, neurodegenerative disorders, and infectious diseases. Additionally, the rising demand for early and accurate disease detection coupled with advancements in exosome isolation and analysis technologies will boost the segment expansion.
Regionally, the Asia Pacific exosomes market is projected to exhibit robust growth rate through 2032 owing to the increasing research activities and the expanding biotechnology and healthcare sectors across the region. The rising prevalence of chronic diseases and the growing interest in precision medicine are surging the demand for exosome-based diagnostics and therapeutics. Additionally, the growing collaborative efforts between research institutions and biotech companies in several Asian countries is fostering innovations in exosome applications, propelling the regional industry growth.